Dark

Check out our Level2View

BSEM
BIOSTEM TECHNOLOGIES NEW
stock OTC

EOD

Jul 31, 2026

3.31USD+3.258%(+0.10)90,318

Pre-market

0.00USD-100.000%(-3.21)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Nov 1, 2021

09:00AM EDT BioStem Technologies Announces Veterans Day Fundraiser to Support GlobeNewswire Inc

Aug 25, 2021

11:15AM EDT BioStem Technologies Reports Record Breaking Second Quarter Sales GlobeNewswire Inc

Jul 23, 2021

09:00AM EDT BioStem Technologies, Inc. Awarded Q Code for VENDAJE GlobeNewswire Inc

May 24, 2021

11:35AM EDT BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its first quarter financial reports for 2021. GlobeNewswire Inc

Apr 22, 2021

11:27AM EDT Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness Benzinga

Apr 20, 2021

09:00AM EDT BioStem Technologies, Inc., Announces the Addition of Three Key GlobeNewswire Inc

Apr 15, 2021

09:00AM EDT BioStem Technologies, Inc. Announces Launch of National Sales GlobeNewswire Inc

Apr 5, 2021

09:00AM EDT BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies, today reported financial results for the three and twelve months ended December 31, 2020. GlobeNewswire Inc

Mar 25, 2021

09:00AM EDT BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry GlobeNewswire Inc

Mar 15, 2021

09:00AM EDT BioStem Technologies Engages D. Brooks & Associates for 2020 and GlobeNewswire Inc

Dec 24, 2020

02:00PM EST BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its quarterly reports for 2020 to become current with OTC Markets. GlobeNewswire Inc

Oct 27, 2020

09:00AM EDT BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced the launch of AEON, the 6th and newest addition to the Companys perinatal tissue allograft platform. GlobeNewswire Inc

Sep 1, 2020

05:00PM EDT BioStem Technologies, in Partnership with Veterans Medical GlobeNewswire Inc

Aug 11, 2020

09:00AM EDT BioStem Life Sciences Signs Manufacturing Agreement for Amniotic GlobeNewswire Inc

Jul 22, 2020

05:00PM EDT BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based allografts for use in regenerative therapies, today announced that it expects to file its annual and quarterly reports for the years 2018, 2019 and 2020 to become current with OTC Markets in late 2020. GlobeNewswire Inc

Jul 15, 2020

09:00AM EDT BioStem Life Sciences Receives Accreditation by The American GlobeNewswire Inc

Share